During the past decade, Lakeland Regional Medical Center conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 7 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lakeland Regional Medical Center" #1 sponsor was "Boston Scientific Corporation" with 7 trials, followed by "Abbott Medical Devices" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "C. R. Bard" with 2 trials sponsored and "Sanofi" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lakeland Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "AbCellera Biologics Inc." with 1 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "EKOS Corporation" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Lakeland Regional Medical Center" are "Stroke" (4 trials), "Colorectal Cancer" (2 trials), "Coronary Artery Disease" (2 trials), "Heart Failure" (2 trials) and "Prostate Cancer" (2 trials). Many other conditions were trialed in "Lakeland Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Lakeland Regional Medical Center" are "Drug" (14 trials), "Device" (10 trials), "Other" (5 trials), "Procedure" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "oxaliplatin" (2 trials), "ACUITY X4 quadripolar coronary venous lead and RELIANCE 4-FRONT defibrillation lead" (1 trials), "Bamlanivimab" (1 trials) and "Bebtelovimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lakeland Regional Medical Center" are 24 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Lakeland Regional Medical Center". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Lakeland Regional Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Lakeland Regional Medical Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 10 trials that are defined as “Not Applicable".

Lakeland Regional Medical Center has several departments that took part in Clinical trials: "Lakeland Regional Cancer Center" - 129 trials